• Angiotensin II in Vascular Research: Protocols & Innovations

  2026-06-18

  Leverage Angiotensin II for precise modeling of vascular smooth muscle cell hypertrophy and inflammation. Discover optimized workflows, troubleshooting tactics, and a reference-backed innovation for reliable cardiovascular remodeling assays.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Mechanistic

  2026-06-18

  Wang et al. (2018) systematically dissected how genotype III grass carp reovirus (GCRV104) enters host kidney cells, revealing a dependency on clathrin-mediated, pH- and dynamin-dependent endocytosis. This mechanistic clarity advances both aquatic virology and the broader understanding of endocytic uptake, informing antiviral strategy development and experimental design in ion channel and cellular endocytosis research.

• 4μ8C: Selective IRE1 RNase Inhibitor for ER Stress Modulatio

  2026-06-17

  4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) is a potent and selective unfolded protein response inhibitor targeting IRE1 RNase activity. It enables precise dissection of ER stress signaling in cancer research, with proven in vitro selectivity but notable solubility and pharmacokinetic limitations.

• Steroid-Induced Protoplast Lysis: Mechanisms and Modulators

  2026-06-17

  This study provides a systematic analysis of how synthetic steroids induce lysis in bacterial protoplasts, revealing that direct membrane disruption, rather than cell wall interaction or chelation, underpins antimicrobial activity. The findings clarify the stabilizing and antagonistic effects of various compounds, helping refine experimental approaches to membrane-targeted antimicrobial research.

• Neuromedin S (rat): Technical Use and Handling Guidance

  2026-06-16

  Neuromedin S (rat) is a chemically defined peptide agonist for activating neuromedin U receptor signaling in rat-based GPCR/G protein pathway research. This product addresses the need for reproducibility and precise ligand identity in controlled laboratory assays but is not intended for diagnostic or therapeutic applications.

• Fenofibrate as a PPARα Agonist: Workflows for Liver & Cancer

  2026-06-16

  Fenofibrate is a potent PPARα agonist uniquely suited for dissecting lipid metabolism and cancer pathways, with proven age-independent effects on liver physiology. This guide translates the latest mechanistic findings and experimental data into actionable workflows, troubleshooting, and comparative insights for advanced metabolic and oncology research.

• Vardenafil HCl Trihydrate: Enhancing Proteoform-Specific PDE

  2026-06-15

  Explore how Vardenafil HCl Trihydrate empowers proteoform-specific phosphodiesterase research with unmatched potency and selectivity. This article uniquely connects cutting-edge proteomics with practical assay workflows, advancing smooth muscle and cGMP pathway studies.

• Ivermectin: Mechanistic Clarity and Strategy for Translation

  2026-06-15

  This thought-leadership article offers translational researchers a nuanced synthesis of Ivermectin’s mechanistic foundations, strategic guidance for anti-parasitic research, and cross-domain insights. By bridging evidence-based biological rationale with practical protocol recommendations, and contextualizing recent advances in tumor biology, it positions Ivermectin as an indispensable tool in the evolving landscape of parasitology drug development.

• AMD-070 Hydrochloride: Selective CXCR4 Antagonist for WHIM a

  2026-06-14

  Mavorixafor hydrochloride (AMD-070 hydrochloride) is a potent, oral CXCR4 antagonist with proven efficacy in WHIM syndrome and promising utility in anti-HIV research. Controlled trials demonstrate significant increases in neutrophil and lymphocyte counts and a 60% reduction in infection rates. The compound’s solubility and safety profile support its use in translational and cell-based studies.

• Bacitracin (B1670): Technical Workflow Guide for Antibacteri

  2026-06-13

  Bacitracin (B1670) is a peptide antibiotic used to inhibit bacterial cell wall and peptidoglycan synthesis, enabling targeted antibacterial research against both gram-positive and gram-negative bacteria. It is strictly intended for controlled laboratory protocols and not for diagnostic or medical applications.

• NSC 87877: Transforming Shp2 Inhibition for Translational Su

  2026-06-12

  This thought-leadership article explores the strategic deployment of NSC 87877 as a selective Shp2 inhibitor in the context of neuroinflammation, cancer, and translational research. Highlighting the pivotal Nespas/miR-383-3p/Shp2 axis, it integrates new mechanistic findings, practical protocol guidance, and a forward-looking perspective for maximizing translational impact.

• Sulfachloropyridazine Shifts Cecal Microbiota in E. tenella

  2026-06-12

  This study systematically investigates how sulfachloropyridazine, ethanamizuril, and their combination modulate the cecal microbial community and metabolome in chickens challenged with Eimeria tenella. The work highlights drug-specific effects on pathogenic and commensal bacteria, with practical implications for monitoring anticoccidial efficacy and designing targeted interventions in poultry infection models.

• Precision Phosphatase Inhibition: Elevating Translational Re

  2026-06-11

  Unlocking the full complexity of phosphorylation-driven signaling requires rigorous preservation of protein phosphorylation states during sample preparation. This thought-leadership article blends mechanistic insight from autophagy research with actionable guidance for translational scientists, highlighting how advanced reagents like Phosphatase Inhibitor Cocktail 3 (100X in DMSO) can drive reproducibility and discovery in models of metabolic disease and beyond.

• Cell Integrity Constraints Define Ploidy Limits in Budding Y

  2026-06-11

  This study demonstrates that cell surface stress fundamentally limits the maximum ploidy attainable in Saccharomyces cerevisiae. By linking cell size, membrane integrity, and gene expression, the work offers new mechanistic insights relevant for antifungal and ploidy research.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-06-10

  This study demonstrates that activation of PPARγ regulates the balance between pro- and anti-inflammatory macrophages, alleviating intestinal inflammation in a DSS-induced IBD mouse model through STAT-1/STAT-6 signaling. These findings provide mechanistic insight into immune modulation in IBD and highlight PPARγ as a promising target for translational immunometabolic research.

14760 records 1/984 page Next 12345 下5页 Last page